Timeliness of Tissue-Type Plasminogen Activator Therapy in Acute Ischemic Stroke

C. Fonarow, Gregg; E. Smith, Eric; L. Saver, Jeffrey; J. Reeves, Mathew; L. Bhatt, Deepak; V. Grau‐Sepulveda, Maria; M. Olson, DaiWai; F. Hernandez, Adrian; D. Peterson, Eric; H. Schwamm, Lee

doi:10.1161/circulationaha.110.974675

Public

Timeliness of Tissue-Type Plasminogen Activator Therapy in Acute Ischemic Stroke

Published in Circulation • Feb 11, 2011

Authors:

Gregg C. Fonarow

Eric E. Smith

Jeffrey L. Saver

Abstract

BACKGROUND: The benefits of intravenous tissue-type plasminogen activator (tPA) in acute ischemic stroke are time dependent, and guidelines recommend an arrival to treatment initiation (door-to-needle) time of ≤60 minutes. METHODS AND RESULTS: Data from acute ischemic stroke patients treated with tP...

Subject

Medicine

Stroke (engine)

Tissue plasminogen activator

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!